These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26983770)

  • 1. Glucocorticoids and glucocorticoid receptors: mediators of fatigue?
    Cleare AJ
    Acta Neuropsychiatr; 2003 Dec; 15(6):341-53. PubMed ID: 26983770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroendocrinology of chronic fatigue syndrome.
    Cleare AJ
    Endocr Rev; 2003 Apr; 24(2):236-52. PubMed ID: 12700181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ
    Trends Endocrinol Metab; 2004 Mar; 15(2):55-9. PubMed ID: 15036250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
    Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Van Houdenhove B; Cosyns P; Claes SJ
    Neuropsychobiology; 2007; 55(2):112-20. PubMed ID: 17596739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?
    Van Houdenhove B; Van Den Eede F; Luyten P
    Med Hypotheses; 2009 Jun; 72(6):701-5. PubMed ID: 19237251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early childhood trauma on hypothalamic-pituitary-adrenal (HPA) axis function in patients with Chronic Fatigue Syndrome.
    Kempke S; Luyten P; De Coninck S; Van Houdenhove B; Mayes LC; Claes S
    Psychoneuroendocrinology; 2015 Feb; 52():14-21. PubMed ID: 25459889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.
    Rajeevan MS; Smith AK; Dimulescu I; Unger ER; Vernon SD; Heim C; Reeves WC
    Genes Brain Behav; 2007 Mar; 6(2):167-76. PubMed ID: 16740143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids and acute lung injury.
    Thompson BT
    Crit Care Med; 2003 Apr; 31(4 Suppl):S253-7. PubMed ID: 12682449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment.
    Racciatti D; Guagnano MT; Vecchiet J; De Remigis PL; Pizzigallo E; Della Vecchia R; Di Sciascio T; Merlitti D; Sensi S
    Int J Immunopathol Pharmacol; 2001; 14(1):11-15. PubMed ID: 12622884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine disorder in chronic fatigue syndrome.
    Tomic S; Brkic S; Lendak D; Maric D; Medic Stojanoska M; Novakov Mikic A
    Turk J Med Sci; 2017 Aug; 47(4):1097-1103. PubMed ID: 29154201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.
    Jerjes WK; Cleare AJ; Wessely S; Wood PJ; Taylor NF
    J Affect Disord; 2005 Aug; 87(2-3):299-304. PubMed ID: 15922454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.